文献速递心力衰竭与心肌病

既往左心室射血分数变化方向与射血分数中间值心衰患者临床结局的关联

Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction.
PubMed 文献 · JAMA Cardiol · 2020-01-01

结果显示,LVEF从>50%恶化至中间值的患者,其全因死亡和住院复合风险及心血管死亡和心衰住院复合风险均显著高于从<40%改善至中间值的患者,而改善者与稳定者结局无显著差异。

要点

  • HFmrEF患者中,LVEF从>50%恶化至40%-50%者不良事件风险高于从<40%改善者。
  • LVEF改善至中间值与维持中间值者临床结局无显著差异。
  • 制定HFmrEF管理策略时应考虑既往LVEF的变化方向。

核心结论

  • HFmrEF患者的临床病程受既往LVEF变化方向的显著影响,恶化至中间值者不良事件风险更高。

主要发现

  • 448例HFmrEF患者中,278例(62.1%)为男性,平均(SD)年龄67.4(9.7)岁。
  • LVEF从<40%改善至中间值者157例(35.0%),从>50%恶化至中间值者224例(50.0%),维持40%-50%者67例(15.0%)。
  • LVEF改善者与稳定者之间结局无显著差异。

临床怎么用

  • 临床评估HFmrEF患者时,应追溯既往LVEF变化方向,恶化至中间值者可能需更积极管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Patients categorized as having heart failure (HF) with left ventricular ejection fraction (LVEF) in the midrange between 40% and 50% (HFmrEF) are known to be at increased risk of future events. Although patients can transition into the midrange through either improvement or deterioration in their LVEF, there is limited information available assessing the association of directional change in LVEF with future events. Understanding the association between change in LVEF and the clinical course of patients with HFmrEF would be of value in guiding management strategies. OBJECTIVE: To determine whether risk of clinical events experienced by patients with HFmrEF varies according to whether LVEF improved or deteriorated into the range of 40% to 50% from previous measurements. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective cohort study, patients were identified from the electronic health records at the UC San Diego Health System who had an LVEF measured between 40% and 50% on transthoracic echocardiography (TTE) performed during the calendar year of 2015 and who also had at least 1 prior TTE for comparison. The clinical course of these patients was then followed from the time of the index TTE through December 2018. Data were analyzed from January to March 2019. MAIN OUTCOMES AND MEASURES: The composite of all-cause mortality and all-cause hospitalization, the composite of cardiovascular mortality and HF hospitalization, and each of the individual components. RESULTS: Of the 448 patients who were identified with HFmrEF, 278 (62.1%) were male, and the mean (SD) age was 67.4 (9.7) years. Left ventricular ejection fraction improved from less than 40% in 157 patients (35.0%), deteriorated from greater than 50% in 224 patients (50.0%), and remained between 40% and 50% over time in 67 patients (15.0%). Compared with patients whose LVEF improved from less than 40% to midrange levels, patients whose LVEF deteriorated from greater than 50% had higher risk of all-cause mortality and hospitalization (hazard ratio, 1.34; 95% CI, 1.10-1.82; P = .03) and of cardiovascular mortality and HF hospitalization (hazard ratio, 1.71; 95% CI, 1.08-2.50; P = .02), and these differences persisted after multivariable analysis. Outcomes did not differ significantly between patients whose LVEF improved and those in whom it remained stable. CONCLUSION AND RELEVANCE: In a cohort of patients with HFmrEF from a large academic medical center, the clinical course was strongly influenced by the directional change in LVEF from prior study. Patients whose LVEF deteriorated into midrange levels experienced a significantly higher risk of adverse clinical events than patients whose LVEF had improved. These results suggest that directional change in LVEF from prior measurements should be considered when devising management strategies for patients with HFmrEF.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Brann A, Janvanishstaporn S, Greenberg B, et al. Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction. JAMA Cardiol. 2020. PMID: 32936274. doi:10.1001/jamacardio.2020.2081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。